Saturday, August 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Earnings

Atlassian’s €128.80 Spike: A Profitability Inflection Point Arrives Just as Growth Slows

Rodolfo Hanigan by Rodolfo Hanigan
August 8, 2026
in Earnings, Tech & Software, Turnaround
0
Atlassian Stock
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

The software maker that spent years convincing investors to look past red ink finally handed them a reason to cheer. Atlassian’s fourth-quarter results, released Friday, sent the stock soaring 34.87% to close at €128.80 — a move that recast the entire narrative around the company’s cloud transition and its long road to profitability.

The headline number that did the heavy lifting: a GAAP net profit of $139.1 million, a milestone after years of net losses. The operating margin hit 12% in the final quarter, and the market treated that as the proof of sustainability it had been waiting for. On the week, the stock is up 47.03%, and over the trailing 30 days it has gained 72.19%.

Yet the rally masks a more complicated picture. Despite Friday’s surge, the shares remain down 7.43% on the year and still sit 20.52% below the 52-week high of €162.06. The question now is whether this marks the start of a durable re-rating or a sharp, short-lived reprieve.

The Bull Case: Cloud Momentum and a CEO Putting Money Where His Mouth Is

Revenue for the quarter came in at $1.766 billion, up 28% year over year and comfortably ahead of the $1.663 billion analysts had penciled in. The cloud segment — the company’s primary growth engine — accelerated to 31% growth, a pickup from prior quarters. GAAP operating income swung from a loss in the year-ago period to $211 million, with the operating margin climbing to 36% from 24%.

Perhaps the most telling indicator of future demand: remaining performance obligations jumped 44% to $4.8 billion, signaling a pipeline that has yet to fully translate into recognized revenue. Free cash flow landed at $475 million.

Adding to the bullish momentum, co-founder and CEO Mike Cannon-Brookes announced plans to purchase up to $250 million worth of shares through a structured trading plan. That insider signal, combined with the earnings beat, drew a wave of analyst revisions. TD Cowen lifted its price target to $145 from $105 but kept a neutral stance. BTIG moved to $180 and Jefferies to $200, both with buy ratings.

The average analyst price target now sits at €121.41 — roughly 5.7% below Friday’s close — suggesting the professional consensus sees the stock as modestly overvalued at current levels.

Should investors sell immediately? Or is it worth buying Atlassian?

The Bear Case: A Growth Cliff and a Stretched Chart

The optimism comes with a significant caveat: management’s own guidance points to a sharp deceleration. Revenue growth is expected to fall from 26% in the past fiscal year to around 13% in fiscal 2027. The data-center segment is the sore spot, with a projected 17% decline as customers are pushed toward cloud offerings.

Technical indicators add to the caution. The 14-day relative strength index sits at 78, deep in overbought territory, while the annualized 30-day volatility exceeds 125% — a level that historically precedes sharp pullbacks. The stock’s recent run has been extraordinary, but the risk of a violent reversal is baked into the tape.

There’s also an operational wrinkle: the recently disclosed “RovoBlast” security vulnerability in the company’s AI assistant serves as a reminder that the aggressive push into artificial intelligence carries its own set of risks. And if the anticipated growth slowdown in 2027 coincides with margin compression — say, from heavier AI infrastructure spending — the current enthusiasm could fade quickly.

The Reconciliation: What the Next Quarter Will Tell

The central tension is straightforward. Atlassian has finally demonstrated it can generate meaningful GAAP profits, and its cloud business is firing on all cylinders. But the company is simultaneously guiding toward a much slower growth trajectory, and its data-center business — once a reliable contributor — is now in managed decline.

The €121.41 analyst target offers a rough line in the sand. A sustained move below that level would suggest the post-earnings euphoria is cooling. The next real test comes with the fiscal first-quarter report, when investors will see whether the projected “sharp slowdown” is conservative guidance or the new reality.

For now, the market has chosen to celebrate the profitability breakthrough. Whether that celebration extends beyond a single session depends on Atlassian’s ability to keep margins expanding even as growth decelerates — and to prove that the cloud transition, now years in the making, can carry the company through the slower patch ahead.

Ad

Atlassian Stock: Buy or Sell?! New Atlassian Analysis from August 8 delivers the answer:

The latest Atlassian figures speak for themselves: Urgent action needed for Atlassian investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 8.

Atlassian: Buy or sell? Read more here...

Tags: Atlassian
Rodolfo Hanigan

Rodolfo Hanigan

Related Posts

Applovin Stock
Analysis

AppLovin’s $40 Billion Wake-Up Call: When a 53% Growth Rate Isn’t Enough

August 8, 2026
Amazon Stock
E-Commerce

Amazon’s Three-Trillion-Dollar Moment: A Founder’s Exit, a $220 Billion Wager, and the Fine Print Behind the Record Numbers

August 8, 2026
Novo Nordisk Stock
Earnings

Novo Nordisk Faces a Harder Sell as Forecasts, Trials and Rivalry All Tighten

August 8, 2026
Next Post
Applovin Stock

AppLovin's $40 Billion Wake-Up Call: When a 53% Growth Rate Isn't Enough

FALLBACK Stock

Milan Fertility Clinic Suspended After Embryo Mix-Up Sparks Safety Reforms Across Europe

Recommended

Unitedhealth Stock

UnitedHealth Shifts Strategy with Major Business Restructuring

10 months ago
Pepsi Stock

Activist Investor Elliott Management Pushes for Overhaul at PepsiCo

11 months ago
SpringWorks Therapeutics Stock

Merck KGaA’s Strategic SpringWorks Acquisition Yields Key European Approvals

11 months ago
Enel Spa Stock

Enel Spa Stock: Billion-Euro Buyback Fails to Lift Shares

1 year ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Amazon’s Three-Trillion-Dollar Moment: A Founder’s Exit, a $220 Billion Wager, and the Fine Print Behind the Record Numbers

The AI Payoff Shifts: Airbnb, SpaceX, and Crypto Show Their Hand

Novo Nordisk Faces a Harder Sell as Forecasts, Trials and Rivalry All Tighten

Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding

SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market

Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

Trending

FALLBACK Stock
Healthcare

Milan Fertility Clinic Suspended After Embryo Mix-Up Sparks Safety Reforms Across Europe

by SiterGedge
August 8, 2026
0

The moment a surgical team realized what had happened, the procedure was already over. A woman at...

Applovin Stock

AppLovin’s $40 Billion Wake-Up Call: When a 53% Growth Rate Isn’t Enough

August 8, 2026
Atlassian Stock

Atlassian’s €128.80 Spike: A Profitability Inflection Point Arrives Just as Growth Slows

August 8, 2026
Amazon Stock

Amazon’s Three-Trillion-Dollar Moment: A Founder’s Exit, a $220 Billion Wager, and the Fine Print Behind the Record Numbers

August 8, 2026
Airbnb Stock

The AI Payoff Shifts: Airbnb, SpaceX, and Crypto Show Their Hand

August 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Milan Fertility Clinic Suspended After Embryo Mix-Up Sparks Safety Reforms Across Europe
  • AppLovin’s $40 Billion Wake-Up Call: When a 53% Growth Rate Isn’t Enough
  • Atlassian’s €128.80 Spike: A Profitability Inflection Point Arrives Just as Growth Slows

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com